CBDBY(CBDBY)
CBDBY
No analyst ratings available
No analyst price targets available for CBDBY
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.44%
EPS—
FY2028
Rev-0.72%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $19.77B | $20.85B | $20.70B |
| Low | $19.13B | $20.17B | $20.02B |
| High | $20.43B | $21.54B | $21.39B |
| EBITDA Avg | $2.46B | $2.60B | $2.58B |
| Low | $2.38B | $2.51B | $2.49B |
| High | $2.54B | $2.68B | $2.66B |
| EBIT Avg | $432M | $456M | $452M |
| Low | $418M | $441M | $438M |
| High | $447M | $471M | $468M |
| Net Income Avg | $-358M | $-187M | $-99M |
| Low | $-374M | $-195M | $-103M |
| High | $-343M | $-179M | $-94M |
| EPS Avg | $-0.80 | $-0.42 | $-0.22 |
| Low | $-0.84 | $-0.44 | $-0.23 |
| High | $-0.77 | $-0.40 | $-0.21 |
| Analysts (Rev / EPS) | 4 / 1 | 3 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $4.74B | $5.52B |
| Low | $4.74B | $5.52B |
| High | $4.74B | $5.52B |
| EBITDA Avg | $590M | $688M |
| Low | $590M | $688M |
| High | $590M | $688M |
| EBIT Avg | $104M | $121M |
| Low | $104M | $121M |
| High | $104M | $121M |
| Net Income Avg | $-72M | $-6M |
| Low | $-72M | $-6M |
| High | $-72M | $-6M |
| EPS Avg | $-0.15 | $-0.01 |
| Low | $-0.15 | $-0.01 |
| High | $-0.15 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions